Bafna Pharmaceuticals today reported a widening of its standalone net loss to Rs 2.08 crore for the quarter ended March 31, 2012, over the same period previous fiscal.
The company had posted a net loss of Rs 85 lakh for the quarter ended March 31, 2011, Bafna Pharmaceuticals said in a filing to BSE.
The net sales of the company increased to Rs 32.73 crore in the quarter from Rs 29.60 crore in same period year ago.
The company's net profit for 2011-12 fiscal stood at Rs 20.74 crore against Rs 33.48 crore for the previous fiscal.
Net sales of the company rose to Rs 120.98 crore for FY 12 from Rs 101.30 crore for FY11.
Shares of Bafna Pharmaceuticals were today trading at Rs 49 in the afternoon trade on BSE, down 1.21% from its previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app